0006-4305 : Renflexis 100 mg Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 0006-4305
Labeler: Merck Sharp & Dohme Corp.
Product Type: Human Prescription Drug
Drug Name:  Renflexis
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: BLA761054
Rev. Date: 


NDC Package Codes:

  • 0006-4305-02: 1 VIAL IN 1 CARTON (0006‑4305‑02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL (0006‑4305‑01)

Active Ingredients:

  • Infliximab

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Tumor Necrosis Factor Blocker [EPC]
  • Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Related Products:

Based on records with the same trade name.
  • 78206-162 Renflexis 100 mg Intravenous Injection, Powder, Lyophilized, for Solution by Organon LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0006-4305 QR Code

< Prev: 0006-4293Next: 0006-4309 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.